MHRA Class 4 Medicines Defect Notification: Apixaban 2.5mg and 5mg tablets (Sandoz Limited)
MHRA Class 4 Medicines Defect Notification: Apixaban 2.5mg and 5mg tablets (Sandoz Limited) Drug alert number: EL(26)A/17 Date issued: 26 March 2026 Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information. DMRC reference number: DMRC-38614094 Marketing Authorisation Holder: Sandoz Limited Medicine Details Product [...]
The post MHRA Class 4 Medicines Defect Notification: Apixaban 2.5mg and 5mg tablets (Sandoz Limited) appeared first on Community Pharmacy England.
Recent Comments